134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies
Sign Up to like & getrecommendations! Published in 2018 at "CNS Spectrums"
DOI: 10.1017/s1092852918000305
Abstract: Abstract Introduction Tardive dyskinesia (TD) is an involuntary movement disorder that is often irreversible, can affect any body region, and can be debilitating. In the ARM-TDand AIM-TD studies, deutetrabenazine treatment demonstrated statistically and clinically significant… read more here.
Keywords: aim; treatment; deutetrabenazine treatment; deutetrabenazine ... See more keywords
Deutetrabenazine for the treatment of Huntington’s chorea
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2018.1500178
Abstract: ABSTRACT Introduction: Huntington’s disease (HD) is an inherited neurodegenerative disorder for which no disease-modifying treatment is currently available. Only symptomatic treatment can be offered. Chorea is the most common motor manifestation of HD and may… read more here.
Keywords: treatment; huntington; deutetrabenazine treatment; chorea ... See more keywords